Literature DB >> 20322019

The Clinical Use of Sulfanilamide, Sulfapyridine, Sulfathiazole, Sulfaguanidine, and Sulfadiazine in the Prophylaxis and Treatment of Infections.

P H Long.   

Abstract

Entities:  

Year:  1941        PMID: 20322019      PMCID: PMC1826721     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  THE PROPHYLACTIC USE OF SULFANILAMIDE IN STREPTOCOCCAL RESPIRATORY INFECTIONS, WITH ESPECIAL REFERENCE TO RHEUMATIC FEVER.

Authors:  A F Coburn; L V Moore
Journal:  J Clin Invest       Date:  1939-01       Impact factor: 14.808

  1 in total
  7 in total

1.  Sulfamethazine: In Vitro Action on Enteric Pathogens as Compared with Sulfadiazine and Sulfamerazine.

Authors:  F B Schweinburg; I J Yetwin
Journal:  J Bacteriol       Date:  1945-02       Impact factor: 3.490

2.  CHEMOTHERAPY OF PNEUMOCOCCIC MENINGITIS WITH SPECIAL REFERENCE TO SULFATHIAZOLE.

Authors:  F B Cooper; P Gross; M L Hagan
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

3.  Some Recent Advances in Drug Therapy.

Authors:  L S Goodman
Journal:  Bull N Y Acad Med       Date:  1942-02

4.  Sulfonamide Chemotherapy.

Authors:  J R Morgan
Journal:  Can Med Assoc J       Date:  1943-08       Impact factor: 8.262

5.  The Intracranial Use of Sulfadiazine: Experimental Study of the Histology and Rate of Absorption.

Authors:  E F Hurteau
Journal:  Can Med Assoc J       Date:  1942-01       Impact factor: 8.262

6.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 7.  The management of subacute bacterial endocarditis superimposed on rheumatic heart disease in the immediate pre-penicillin era: the case of Pasquale Imperato.

Authors:  Pascal James Imperato; Austin C Imperato; Gavin H Imperato
Journal:  J Community Health       Date:  2012-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.